• ABSTRACT
    • The prevention and treatment of venous thromboembolic disease after total hip arthroplasty is a controversial issue that is important to orthopaedic surgeons and their patients. Important considerations include current risk factors, the efficacy and safety of preventive agents, the optimal duration of treatment with prophylaxis, the value of routine screening, and treatment recommendations after total hip arthroplasty.